Compare ILMN & RYAAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ILMN | RYAAY |
|---|---|---|
| Founded | 1998 | 1985 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9B | 31.1B |
| IPO Year | 2000 | 1997 |
| Metric | ILMN | RYAAY |
|---|---|---|
| Price | $129.59 | $70.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 1 |
| Target Price | ★ $117.27 | $76.00 |
| AVG Volume (30 Days) | ★ 1.7M | 1.1M |
| Earning Date | 02-05-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 1.17% |
| EPS Growth | N/A | ★ 62.72 |
| EPS | ★ 4.46 | 2.57 |
| Revenue | $4,288,000,000.00 | ★ $17,686,260,708.00 |
| Revenue This Year | N/A | $11.08 |
| Revenue Next Year | $2.08 | $5.20 |
| P/E Ratio | $29.49 | ★ $13.20 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $68.70 | $38.52 |
| 52 Week High | $153.06 | $71.82 |
| Indicator | ILMN | RYAAY |
|---|---|---|
| Relative Strength Index (RSI) | 56.87 | 69.27 |
| Support Level | $126.44 | $65.83 |
| Resistance Level | $137.09 | $71.82 |
| Average True Range (ATR) | 3.66 | 1.18 |
| MACD | -0.62 | 0.42 |
| Stochastic Oscillator | 42.96 | 87.86 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.